Discover 282 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Dakota offers a range of options for both healthy volunteers interested in paid clinical studies and individuals with specific health conditions. Major research hubs in Sioux Falls, Rapid City, and Aberdeen are currently recruiting participants, allowing access to groundbreaking treatments and advanced medical support.
Filter
1
Filter results
Results: 282
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
for
Endometrial Cancer
Location: Buffalo NY, Pittsburgh PA, Orlando FL, Tampa FL,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: Female
Age: 18 - 70
Code: NCT06481592
Phase2, Recruiting
Smoking Cessation Intervention for American Indian Women Experiencing Intimate Partner Violence
for
Smoking Cessation, Cigarette Smoking
Location: Rapid City SD
Sponsor: Black Hills Center for American Indian Health
Sex: Female
Age: 18+
Code: NCT06357767
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Get alerts for new trials in your area by subscribing now
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Durham NC, Roanoke VA, Orange City FL, Fort Myers FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for
Malignant Female Reproductive System Neoplasm,
Location: Brewer ME, Augusta ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06126276
Phase2, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Featured
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for
Atopic Dermatitis
Location: Quincy MA, Boston MA, New Haven CT, Lebanon NH, Quebec,
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT06389136
Phase3, Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Halifax, New York NY, Morehead City NC, Richmond VA,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase2, Recruiting
Effect of a Synbiotic Supplement on a High-protein Diet
for
Obesity
Location: Brookings SD
Sponsor: South Dakota State University
Sex: All
Age: 18 - 70+
Code: NCT03123510
Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: East Setauket NY, Stamford CT, Baltimore MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
for
Persistent Corneal Epithelial Defect
Location: Boston MA, Norfolk VA, Miami FL, Jacksonville FL,
Sponsor: Dompé Farmaceutici S.p.A
Sex: All
Age: 18+
Code: NCT07519902
Phase3, Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
for
Urge Urinary Incontinence
Location: Philadelphia PA, Allentown PA, Charleston SC,
Sponsor: MedtronicNeuro
Sex: All
Age: 18+
Code: NCT07456865
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
for
IgAN, C3G, Complement-mediated Kidney Disease,
Location: Great Neck NY, Shelby MI, Iowa City IA, Shreveport LA,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06989359
Phase2, Recruiting
Alleviant ALLAY-HF Study
for
Heart Failure
Location: Boston MA, Stony Brook NY, Montreal, New York NY,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 40+
Code: NCT05685303
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: New Bedford MA, Miami FL, Roanoke VA, Uniontown PA,